SAVA Q1 2022 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$116M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$15M

Operating Income

-$18M

Net Income

-$18M

EPS (Diluted)

$-0.43

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$495,000

Balance Sheet

Total Assets

$244M

Total Liabilities

$7M

Stockholders' Equity

$237M

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$15M	-$3M	-489.4%
Operating Income	-$18M	-$4M	-404.4%
Net Income	-$18M	-$4M	-397.1%